جست‌وجوی استاد و پژوهشگر

Nicholas Cumminsمشاهده پروفایل

مدرس

• Artificial Intelligence
• Machine Learning
• Affective Computing
• +۶ مورد دیگر

Dr. Nicholas Cummins is a Lecturer in AI for Speech Analysis at King’s College London, specializing in applying machine learning to health conditions, particularly mental health disorders. He holds roles in the Department of Biostatistics & Health Informatics and is affiliated with the NIHR Maudsley Biomedical Research Centre. His research focuses on speech processing, affective computing, and digital phenotyping, with projects like RADAR-CNS and DE-ENIGMA. He earned his PhD from UNSW Australia (2016) and conducted postdoctoral work in Germany before becoming habilitation candidate at the University of Augsburg. Education: PhD in Electrical Engineering, UNSW Australia (2016) Habilitation Candidate, Chair of Embedded Intelligence for Healthcare, University of Augsburg Research Interests: Machine learning for mental health monitoring Speech-based biomarkers for depression and psychosis Wearable device integration for health tracking Multilingual speech analysis Key Projects: RADAR-CNS: Data analysis for neurological conditions DE-ENIGMA, TAPAS, sustAGE (Horizon 2020) National Science Foundation of China project on speech-based depression diagnosis Grants & Awards: Over 100 peer-reviewed publications (h-index: 23) NSFC-funded project on speech analysis for depression Reviewer for IEEE, ACM, ISCA journals Labs & Teams: Involved in the NIHR HealthTech Research Centre in Brain Health and the EMBRACE initiative for maternal/child health with AI.

Mariana P. Socalمشاهده پروفایل

دانشیار

• Pharmaceutical Policy
• Drug Pricing
• Prescription Drugs
• +۱۱ مورد دیگر

Mariana P. Socal is an Associate Professor at the Johns Hopkins Bloomberg School of Public Health in the Department of Health Policy and Management, with a joint appointment at the Carey Business School. Her work bridges medicine, public health, and policy, focusing on pharmaceutical access and affordability in the U.S. Education: PhD in Public Health/Health Systems, Johns Hopkins Bloomberg School of Public Health (2017) MPP, Princeton University (2010) MSc, Universidade Federal do Rio Grande do Sul (2008) MD, Universidade Federal do Rio Grande do Sul (2000) Her research centers on pharmaceutical policy, including drug pricing, supply chains, biosimilars, insulin, gene therapies, Medicare, and FDA regulation. She investigates how policy interventions can reduce drug costs while preserving access, with a focus on vulnerable populations and systemic reform. Her recent publications reflect a strong focus on drug shortages, gene therapy access, insulin affordability, and state-level pharmaceutical initiatives like CalRx. Her work frequently appears in top-tier journals such as JAMA, Annals of Internal Medicine, and Health Affairs, highlighting her influence in health policy discourse. Scientific Awards: Member, WHO Technical Advisory Group on Pricing Policies for Medicines (2023–2027) Johns Hopkins NEXUS Research Award (2024) Excellence in U.S. Public Health Practice Award (2022) Multiple Excellence in Teaching Awards (2019–2025) Golden Apple Award (2022) Gordis Teaching Fellowships (2013, 2015) Prof. Socal has testified before the U.S. Congress and the FDA on drug pricing and regulation. She collaborates with state governments, including California’s CalRx initiative, and leads the Prescription Drug Supply Chain Data Dashboard (https://supplychain.jhu.edu). She is actively involved in advising and public engagement, though no specific students are listed. She has no indication of part-time status, retirement, or former staff designation.

Mark Sleeمشاهده پروفایل

دانشیار

• Clinical Neuroimmunology
• Multiple Sclerosis
• Medical Education
• +۴ مورد دیگر

Associate Professor Mark Slee is a clinical academic neurologist at Flinders University , affiliated with the College of Medicine and Public Health . His work focuses on immune-mediated neurological disorders, particularly Multiple Sclerosis , alongside contributions to Medical Education and Human Research Ethics . Research Interests include: Clinical Neuroimmunology Mitochondrial Biology in Neurodegeneration Disease Modifying Therapies for MS Neurological Disability Assessment Neuroethics and Clinical Training Scientific Awards : Inaugural NHMRC-MSRA Betty Cuthbert Clinical Research Fellowship (2012) Teaching & Leadership : Served as Associate Dean and Head of Medical Science and Technology , coordinating topics like MMED8220 Brain and Behavior and mentoring medical students.

• Survival Analysis
• Nonparametric Regression
• Semiparametric Regression
• +۴ مورد دیگر

Ingrid Van Keilegom is a Full Professor at the Faculty of Economics and Business (FEB) at KU Leuven. She is a member of the LISS – KU Leuven Institute of Sports Science and serves as a program director for the POC Master in Statistics. Senior academic staff member of FEB Council and Campus Council Observer in Faculty of Science Council Member of LStat General Assembly Her research focuses on Survival Analysis and Nonparametric Regression , with expertise in: Dependent Censoring Cure Models Measurement Error Correction Quantile Regression Multivariate Statistical Inference Causal Surrogacy Metrics Recent publications emphasize copula-based methods, quantile regression for censored data, and applications to biomedical and economic forecasting. Key projects include instrumental variable approaches for endogeneity in cure models, bankruptcy prediction via machine learning, and measurement error modeling in multivariate settings. Notable affiliations: Centre for Efficiency and Productivity Analysis Collaborations in pharmaceutical statistics and actuarial science

Marios Georgakisمشاهده پروفایل

پژوهشگر

• Cardiovascular Disease
• Stroke
• Atherosclerosis
• +۸ مورد دیگر

Marios Georgakis is a clinician-scientist and Junior Group Leader at the Institute for Stroke and Dementia Research (ISD) at LMU Munich. He also holds a Visiting Scientist position at the Broad Institute of MIT and Harvard. His research focuses on leveraging multi-omics data and causal inference methods (e.g., Mendelian randomization) to discover drug targets for atherosclerosis, develop personalized risk stratification tools for cerebrovascular disease, and identify in vivo biomarkers of disease activity. His work bridges human genetics, molecular biology, and clinical translation. Education : MD and PhD (Epidemiology) from the National and Kapodistrian University of Athens; doctoral studies in Systemic Neurosciences at LMU Munich. Honors : Emmy Noether Award (DFG), CHARGE Consortium Early Career Achievement Award, Hertie Network Fellowship, and multiple scholarships/fellowships. Research Themes : Drug target discovery for cardiovascular disease via multiomics integration Molecular phenotyping of atherosclerosis using single-cell RNA-seq and spatial transcriptomics Development of AI-driven tools for vascular imaging and aging Genetic studies of inflammation, cytokines, and stroke subtypes Causal inference in vascular risk prediction and post-stroke outcomes Recent Article Trends : His team's publications (2024-2020) emphasize: Proteogenomic and genetic studies of atherosclerosis Cytokine signaling pathways (e.g., IL-6, CCL2/CCR2) Polygenic and genomic risk scores for stroke Multi-omics biomarkers in cerebrovascular disease Clinical translation of Mendelian randomization findings Meta-analyses of population-based data Scientific Awards : Emmy Noether Group Leader Award (DFG, 2023) CHARGE Consortium Early Career Achievement (2023) Hertie Network Fellowship (2023) Walter-Benjamin Postdoctoral Fellowship (2021-2022) Team Leadership : Georgakis mentors multiple PhD students and postdocs in his lab. His group collaborates with vascular surgeons, neurologists, and computational biologists. Current projects include the AtherOMICS biobank and AI-driven vascular phenotyping tools.

• Parkinson's disease
• Aging and neurodegeneration
• Cellular senescence in nervous system
• +۷ مورد دیگر

Dr. Timothy J. Collier is a Professor of Translational Neuroscience at Michigan State University College of Human Medicine, where he serves as Director of the Michigan State University Udall Center of Excellence in Parkinson's Disease Research. He holds dual appointments in the MSU Neuroscience Program and MSU BioMolecular Science Gateway Faculty, with his laboratory based at the Grand Rapids Research Center. Dr. Collier received his undergraduate training in psychology at the University of Minnesota (B.A., 1974) and completed his graduate studies in psychology and neuroscience at Northwestern University (M.S., 1979; Ph.D., 1983). He conducted postdoctoral training at the University of Rochester with Dr. John Sladek Jr., focusing on cell transplantation in animal models of Parkinson's disease and aging. His research program investigates the fundamental relationship between aging and neurodegenerative diseases, particularly Parkinson's disease. Dr. Collier's laboratory employs a range of models from primary cell culture to nonhuman primates, with current projects examining cellular senescence mechanisms, progerin and klotho gene effects on neurodegeneration, and repurposing existing drugs for Parkinson's treatment. His work bridges basic neuroscience with translational applications, emphasizing how aging serves as an active driver rather than merely a risk factor for neurodegenerative conditions. Analysis of Dr. Collier's recent publications reveals a strong interdisciplinary focus spanning neuroscience, cardiology methodology, and statistical approaches to clinical research. His work demonstrates consistent contributions to understanding Parkinson's disease mechanisms while also advancing methodological approaches in clinical trial design, particularly in cardiology. The integration of aging biology with neurodegenerative disease processes represents a distinctive hallmark of his research program. Dr. Collier maintains active collaborations across multiple research groups studying Parkinson's disease, including the Counts Lab, Gordon Lab, Kanaan Lab, Lipton Lab, Morgan Lab, Sammi Lab, Sortwell Lab, Steece-Collier Lab, and Vega Lab at Michigan State University. His technical expertise encompasses primary neuronal cultures, stereotaxic surgery, immunohistochemistry, brain tissue microdissection, behavioral evaluations of motor performance in rodents, and stereology. These methodologies support his laboratory's investigation of both fundamental mechanisms of neurodegeneration and potential therapeutic interventions.

Daphna Harelمشاهده پروفایل

دانشیار

• Survey Methodology
• Measurement Theory
• LGBTQIA+ Data Analysis
• +۶ مورد دیگر

Daphna Harel (she/her) serves as Associate Professor of Applied Statistics and Director of the A3SR MS Program within the Department of Applied Statistics, Social Science, and Humanities at New York University's Steinhardt School of Culture, Education, and Human Development. She holds leadership roles including PI of the NYU QUEER data lab and membership on the steering committee for the DEPRESSD project. Education: PhD in Mathematics and Statistics from McGill University Harel's research focuses on measurement challenges in survey methodology, particularly for self-reported questionnaires in health and social sciences. Her work bridges theoretical statistics with practical applications in LGBTQIA+ data collection, differential item functioning, and patient-reported outcomes. She develops methodological frameworks for polytomous Item Response Theory and creates guidelines for statistical analysis of complex survey data. Her recent work emphasizes improving statistical practice for LGBTQIA+ populations and advancing queer data collection methods. Her publication portfolio demonstrates consistent focus on measurement validity across diverse health contexts, with recent work expanding into LGBTQIA+ data science. Her research shows increasing emphasis on methodological innovations for gender and sexuality measurement, with multiple publications presented at major conferences including AAPOR 2024 and LGBTQ+ Health Conference 2024. Research Leadership: PI of NYU QUEER data lab (founded Fall 2022) Steering committee member for DEPRESSD project Collaborator with Scleroderma Patient-centered Intervention Network Recipient of NIH R21 funding and NYU intramural grants Harel mentors a diverse team of graduate students through the Applied Statistics for Social Science Research program, focusing on inclusive research methods for marginalized populations. Her grant portfolio includes investigations into transgender voice training, LGBTQIA+ survey methodology, and healthcare access for gender-affirming services. Laboratory Leadership: As founder and PI of the NYU QUEER data lab, Harel leads research projects examining survey question design for gender/sexuality measurement, content moderation effects on hate speech, and accessibility of transgender voice training. The lab operates through collaboration between NYU Steinhardt and the NYU BITS lab, with research assistants drawn from the Applied Statistics MS program.

Martin Bendszusمشاهده پروفایل

استاد

• Magnetic Resonance Imaging
• Neuroradiology
• Neuroimaging
• +۷ مورد دیگر

Professor Martin Bendszus serves as the Medical Director of the Department of Neuroradiology at Heidelberg University Hospital. He has held this position since 2007 and is a leading figure in advanced neuroimaging techniques. His academic career includes medical studies in Bonn, specialized training in Neuroradiology at the University of Würzburg (2003-2007), and a professorship in Neuroimaging at the University of Würzburg. Professor Bendszus's research focuses on innovative imaging methods, particularly in Magnetic Resonance Imaging (MRI). He pioneered Magnet Resonance Neurography for diagnosing peripheral nervous system disorders and made significant contributions to Dental-MRI as a radiation-free diagnostic tool for dental conditions. His expertise also extends to brain and spinal cord diagnostics, including aneurysms, strokes, and arteriovenous malformations. His work bridges clinical practice with advanced imaging research, resulting in numerous high-impact publications across neurology, radiology, and oncology. His publication record shows consistent high-impact contributions, with recent work spanning stroke intervention, neuropathic pain, brain tumor imaging, and advanced MRI techniques. The research trends demonstrate his leadership in translating imaging advances into clinical practice, particularly in time-sensitive neurological conditions where imaging guides critical treatment decisions. Kurt-Decker-Preis Röntgen-Preis Coolidge-Award Lucien-Appel-Award Hermann-Holthusen-Ring der Deutschen Röntgengesellschaft Professor Bendszus leads major multicenter clinical trials and collaborative guideline development efforts, including work with the Response Assessment in Neuro-Oncology (RANO) group and European Association for Neuro-Oncology (EANO). His research has secured significant funding for advancing neuroimaging techniques and their clinical applications. He collaborates extensively with neurologists, neurosurgeons, oncologists, and radiologists to improve diagnostic and therapeutic approaches for neurological conditions. His department serves as a reference center for complex neuroradiological cases and trains the next generation of neuroradiologists. Professor Bendszus maintains active leadership roles in professional societies and regularly contributes to shaping clinical guidelines in neuroimaging and stroke care.

Rish K Paiمشاهده پروفایل

استاد

• Gastrointestinal pathology
• Liver pathology
• Colorectal cancer
• +۶ مورد دیگر

Rish K Pai, M.D., Ph.D. is a Professor of Laboratory Medicine and Pathology at Mayo Clinic in Phoenix, Arizona, with subspecialty expertise in gastrointestinal and hepatic pathology. He serves as Associate Chair of Research for the Department of Laboratory Medicine and Pathology (2020-2023) and was President of the Rodger C. Haggitt Gastrointestinal Pathology Society (2020-2021). Dr. Pai's educational background includes an MD/PhD in Immunology from Case Western Reserve University (2005), followed by residency and fellowship training in Anatomic Pathology and Gastrointestinal and Hepatic Pathology at The University of Chicago Medical Center. His clinical expertise focuses on diagnosis of inflammatory disorders and neoplastic diseases of the gastrointestinal tract and liver. His research interests span gastrointestinal pathology, liver pathology, colorectal cancer genetics, inflammatory bowel disease, and liver transplant pathology. Dr. Pai lectures nationally and internationally on gastrointestinal and hepatic pathology and has directed multiple continuing medical education courses in these areas. He serves as principal investigator of the Colon Cancer Family Registry at Mayo Clinic. Analysis of his recent publications reveals a strong focus on colorectal cancer genetics, molecular pathology of gastrointestinal disorders, and translational applications of pathological findings to improve cancer diagnosis and treatment. His work frequently employs advanced genomic and epidemiological methods including Mendelian randomization and genome-wide association studies. Jack Yardley Investigator Award, Rodger C. Haggitt Gastrointestinal Pathology Society (2019) Rodger C. Haggitt Gastrointestinal Pathology Society Resident Award (2009) Hans Popper Hepatopathology Society Resident Award (2007) Martin Wahl Memorial Fund Award (2005) Dr. Pai has held significant leadership roles including Chair of the Education Committee for the Rodger C. Haggitt Gastrointestinal Pathology Society (2017-2018) and Member of the Education Committee for the United States and Canadian Academy of Pathology (2016-2020). He has also contributed to digital pathology initiatives as a member of the Digital Pathology Practice Subcommittee and the Artificial Intelligence Strategy Working Group at Mayo Clinic.

Ruth Etzioniمشاهده پروفایل

استاد

• Biostatistics
• Cancer Screening
• Early Detection
• +۷ مورد دیگر

Ruth Etzioni is a Professor in the Biostatistics Program within the Public Health Sciences Division at Fred Hutchinson Cancer Center. She holds the Rosalie and Harold Rea Brown Endowed Chair and is a Member of the Translational Data Science Integrated Research Center (TDS IRC) at Fred Hutch. Dr. Etzioni received her PhD in Statistics from Carnegie Mellon University in 1990, following an MS in Statistics from the same institution in 1987, and a BS in Statistics from the University of Cape Town in 1985. As a biostatistician, Dr. Etzioni primarily focuses on cancer screening and early detection, with significant work in prostate and breast cancer. Her research involves developing methods for evaluating diagnostic tests, creating mathematical models to assess screening impact on cancer incidence and mortality, calculating costs and benefits of preventive screening, and tracking population trends related to screening behaviors. She has a longstanding interest in researching overdiagnosis associated with certain screening tests, evaluating novel cancer biomarkers, and tracking patterns and outcomes of cancer care. Her work bridges biostatistics, epidemiology, and clinical oncology to inform evidence-based cancer screening practices. Dr. Etzioni's recent research has increasingly focused on multi-cancer early detection technologies, surveillance-dependent outcomes, and applying sophisticated statistical modeling to understand cancer progression. Her publications demonstrate a strong emphasis on health disparities research, particularly regarding prostate cancer screening in Black men and racial inequities in treatment. Her notable recognition includes: Rosalie and Harold Rea Brown Endowed Chair at Fred Hutchinson Cancer Center Dr. Etzioni leads the biostatistics core for the National Cancer Institute-funded multicenter Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE). She serves as a central consulting resource for prostate cancer investigators at Fred Hutch and the University of Washington, providing expertise in trial design and analysis. Her lab develops innovative statistical and computer modeling approaches to study cancer control outcomes, with expertise in simulation modeling, survival analysis, Bayesian methods, and data visualization. She is a key member of the FHIND Cancer (Fred Hutch Investigators in Novel Diagnostics for Cancer) Research Group, which brings together investigators across multiple disciplines to advance cancer diagnostic technologies and realize the promise of precision oncology.

Kristin J Krosschellمشاهده پروفایل

استاد

• Spinal Muscular Atrophy
• Neuromuscular Disorders
• Pediatric Physical Therapy
• +۳ مورد دیگر

Kristin J Krosschell, DPT serves as Professor in the Department of Physical Therapy and Human Movement Sciences at Northwestern University's Feinberg School of Medicine, with secondary affiliation in Pediatrics. Her primary clinical appointment is at Ann & Robert H. Lurie Children's Hospital of Chicago, and she participates in the Northwestern University Clinical and Translational Sciences Institute (NUCATS). Her research focuses on Spinal Muscular Atrophy (SMA) clinical outcome measures, surrogate endpoints for clinical trials, and exercise/participation interventions. As leader of the Northwestern PT GoBabyGo! Program, she investigates early mobility adaptations for children, while co-leading Pediatric Assessment Labs (PALs) initiatives. Her work emphasizes clinical trial readiness and competency-based education through STEP-IN SMA collaborations. Analysis of her recent publications reveals consistent specialization in SMA therapeutic monitoring, caregiver experience metrics, and evidence-based mobility interventions. Her team develops standardized protocols for contracture management and functional assessments in neuromuscular disorders, directly informing clinical practice guidelines. Selected Honors: Outstanding Research Abstract Award, APTA-CSM (2023) Global Health Honorable Mention Blue Ribbon (2023) Stephen Haley Research Award (2018) Toby Long Best Manuscript Award (2014) Krosschell maintains active industry collaborations through Biogen and Scholar Rock advisory boards while leading multiple national consortia including the Pediatric Neuromuscular Clinical Research Network (PNCRN) and Cure SMA Medical Advisory Board committees. Her federally funded research focuses on outcome measure validation for emerging SMA therapies. She directs Northwestern's Pediatric Physical Therapy specialization within the DPT program, emphasizing neurology/neuromuscular disease competencies and international clinical trial readiness training.

Mathias Fischerمشاهده پروفایل

استاد

• IT and network security
• Resilient distributed systems
• Network monitoring
• +۴ مورد دیگر

Mathias Fischer is Professor for Computer Networks at the University of Hamburg since December 2021, affiliated with the MIN Department of Informatics. He previously served as an assistant professor at Universität Hamburg (2016-2021), University Münster (2015-16), and held postdoctoral positions at the International Computer Science Institute/UC Berkeley (2014-15) and the Center for Advanced Security Research Darmstadt/TU Darmstadt (2012-14). His educational background includes a PhD in Computer Science from TU Ilmenau (2012) and a diploma in Computer Science from the same institution (2008). He also served as Head of Data Literacy Education in IT Support at the University of Hamburg's ISA Center. Professor Fischer's research spans critical areas of modern network infrastructure, with particular emphasis on IT and network security , resilient distributed systems , and network monitoring . His work addresses fundamental challenges in cybersecurity including botnet monitoring, intrusion detection, and critical infrastructure protection. His research group actively investigates P2P networks and develops innovative approaches to network security that balance functionality with privacy preservation. Analysis of his recent publications reveals a strong focus on privacy-enhancing technologies, network security protocols, and resilient distributed systems. His research trajectory shows increasing attention to practical implementations of security solutions for edge computing environments, digital twin networks, and time-sensitive networking applications. The work demonstrates sophisticated integration of cryptographic techniques with network architecture design to address emerging security challenges in distributed systems. Among his notable recognitions are the Claussen-Simon Competition for Universities (2019), the University Prize of the Claussen-Simon Foundation (2019), and an Outstanding Paper Award at ACSAC (2018). Claussen-Simon Competition for Universities (2019) University Prize of the Claussen-Simon Foundation 2019 Outstanding Paper Award at ACSAC (2018) Professor Fischer leads multiple significant research projects including SOVEREIGN (Technologically sovereign security monitoring), RESISTANT (Resilient zero-trust platform for aircraft), and Dynamic situational awareness for rescue teams. His research group comprises numerous doctoral and master's students working on cutting-edge network security challenges. Current projects focus on developing resilient data and AI platforms for crisis situations, security monitoring for critical infrastructures, and innovative home network security solutions. The Computer Networks research group at the University of Hamburg, led by Professor Fischer, maintains active collaborations with industry and academic partners. The group operates specialized laboratories focused on network security testing, intrusion detection systems, and resilient network architectures. Current research directions include QUIC protocol security, federated learning security, and privacy-preserving network analytics, with strong emphasis on practical implementations that address real-world security challenges.

Tülay Kuşمشاهده پروفایل

استاد

• Medical Oncology
• Immunotherapy
• Molecular Targeted Therapies
• +۷ مورد دیگر

Professor Tülay Kuş is a distinguished faculty member at Gaziantep University Faculty of Medicine, Department of Internal Medicine, specializing in Medical Oncology. She currently holds the position of Professor after previously serving as Associate Professor since 2020. Her extensive academic and clinical career spans multiple prestigious institutions including Gaziantep University, Adıyaman University, and Dr. Ersin Arslan Education and Research Hospital. Dr. Kuş completed her medical education at Kocaeli University Faculty of Medicine (1999-2006), followed by medical specialization at Gaziantep University Faculty of Medicine, Department of Internal Medicine (2006-2011 and 2013-2016). Her educational background reflects a strong foundation in internal medicine with specialized focus on oncology. Her research interests span multiple areas of oncology including immunotherapy, molecular targeted therapies, breast cancer, lung cancer, gastrointestinal tumors, gynecological oncology, and radioligand therapy. Dr. Kuş has made significant contributions to the field through her extensive publication record and book chapters on cutting-edge cancer treatments. Analysis of her 15 most recent publications (2022-2024) reveals a strong focus on precision oncology approaches, including molecular biomarkers (KRAS, STK11, KEAP1), advanced imaging techniques (FAPI PET/CT), radioligand therapies (PSMA-targeted), and critical evaluation of clinical trial methodologies. Her work demonstrates expertise across multiple cancer types with particular emphasis on breast, lung, prostate, and gastrointestinal cancers. Scientific Awards 2016 Mesleki Dernekler en iyi sözel bildiri ödülü - Anatolian Medical Oncology Association 2015 Professional Associations Best Oral Presentation - Anatolian Medical Oncology Association Dr. Kuş has successfully supervised multiple graduate students, with completed theses focusing on nivolumab efficacy in lung cancer, imatinib treatment in gastrointestinal stromal tumors, and genetic testing perspectives in breast and ovarian cancer. Her extensive professional development includes participation in numerous national and international oncology courses covering head and neck cancers, hematological malignancies, thoracic oncology, neuroendocrine tumors, and colorectal cancer through institutions including the University of Oxford. She maintains active membership in the Turkish Medical Oncology Association and has contributed significantly to the field through her research, teaching, and clinical practice in medical oncology.

• Cardiovascular Medicine
• Heart Disease Research
• Diabetes and Cardiovascular Disease
• +۴ مورد دیگر

Joakim Alfredsson serves as an Assistant Professor in the Department of Health, Medicine and Care (HMV) within the Faculty of Medicine at Linköping University. His research primarily focuses on cardiovascular medicine with particular emphasis on registry-based studies through the SWEDEHEART registry. His research interests span cardiovascular medicine, heart disease, diabetes-related cardiovascular complications, medical registries, clinical trials, and healthcare quality assessment. Dr. Alfredsson examines critical aspects of post-heart attack care, including disparities in healthcare access for foreign-born patients and the relationship between fatty liver, epicardial fat, and cardiovascular disease in type 2 diabetes patients through the EPSOMiP research project. Analysis of his recent publications (2024-2025) reveals a strong focus on cardiovascular outcomes research using registry data, with particular attention to methodological aspects of clinical studies, quality assessment in medical registries, and interventions to improve post-MI care. His work frequently addresses practical clinical questions with direct implications for patient care and healthcare policy. Dr. Alfredsson collaborates extensively with researchers across Europe, as evidenced by his participation in the EuroHeart initiative and multiple multi-center SWEDEHEART studies. His research has significant implications for standardizing clinical outcome measures and improving cardiovascular care delivery.

• Gene Therapy
• Virology
• Molecular Biology
• +۴ مورد دیگر

Els Henckaerts is a Professor at KU Leuven's Faculty of Medicine, Department of Cellular and Molecular Medicine, where she serves as head of the Trellis Research Group and Virus-Host Interactions and Therapeutic Approaches (VITA) Research Group. She additionally holds leadership roles as division head of the Virology Division Group 4 – Rega and is an active member of the KU Leuven Brain Institute and Leuven Institute for Rare Diseases. Her research integrates virology, molecular biology, and gene therapy with emphasis on adeno-associated virus (AAV) vector development for rare genetic disorders. Current investigations focus on dual AAV intein-based systems for DFNB9 deafness, nanobody-conjugated vectors for enhanced targeting specificity, and preclinical Parkinson's disease therapies. Her work bridges fundamental viral mechanisms with translational applications in inherited sensory and neurodegenerative conditions. Analysis of recent publications reveals dominant themes in AAV vector engineering, analytical characterization methods, and rare disease applications. Key trends include standardization of rAAV production processes, novel conjugation technologies for tissue-specific delivery, and advanced quantification techniques using digital droplet PCR and nanopore sequencing. Henckaerts leads multiple major initiatives including the European Research Alliance for Rare Diseases (2024-2031), an integrated AAV therapy development ecosystem (2025-2030), and the Gene Therapy Innovation Training Network (GET-IN). Her grant portfolio demonstrates significant funding for translational gene therapy projects with clinical endpoints. The Trellis Research Group operates across KU Leuven's Herestraat and Gaston Geenslaan campuses, maintaining specialized facilities for vector production, preclinical testing, and analytical characterization. The team collaborates extensively with clinical partners through the Rega Institute and participates in European consortia focused on rare disease therapeutics.